CAJ | 학술논문

目的：探讨慢性乙型肝炎予以天晴复欣及甘利欣联合治疗的临床研究。方法：入选我院2011年12月-2013年12月慢性乙型肝炎患者80例，按治疗方法的不同分入两组，每组40例，观察组予天晴复欣与甘利欣联合治疗，对照组予甘利欣治疗，比较两组的临床效果和治疗后HBV DNA及ALT水平。结果：观察组、对照组的临床有效率分别为90.0%、65.0%，结果具有统计学意义（P<0.05）；治疗后观察组的HBV DNA水平显著优于对照组（P<0.05）。结论：慢性乙型肝炎病进行天晴复欣和甘利欣联合疗法，临床效果确切，可降低变异病毒的发生，可靠安全，值得临床推广。
목적：탐토만성을형간염여이천청복흔급감리흔연합치료적림상연구。방법：입선아원2011년12월-2013년12월만성을형간염환자80례，안치료방법적불동분입량조，매조40례，관찰조여천청복흔여감리흔연합치료，대조조여감리흔치료，비교량조적림상효과화치료후HBV DNA급ALT수평。결과：관찰조、대조조적림상유효솔분별위90.0%、65.0%，결과구유통계학의의（P<0.05）；치료후관찰조적HBV DNA수평현저우우대조조（P<0.05）。결론：만성을형간염병진행천청복흔화감리흔연합요법，림상효과학절，가강저변이병독적발생，가고안전，치득림상추엄。
Objective:To study the clinical efficacy of Tianqing Fuxin and Ganlixin on treating chronic hepatitis B. Methods:80 patients were randomly divided into two groups. The observation group was given Tianqing Fuxin and Ganlixin, another was given Ganlixin. Results:The total efficiency in the observation group was 90.0%, better than 65.0%in the control, the difference was statistically significant (P<0.05); the HBV and DNA levels in the observation were obviously better (P<0.05). Conclusion: Tianqing Fuxin and Ganlixin come with confirmed effects, it can reduce the occurrence of mutant virus, reliable and safe, and is worthy of clinical promotion.